StockTipsArenaBeta

Gland Pharma LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,974.3+41.90 (+1.43%)
Analysts lean BUY·4 of 6 long-term calls BUY·consensus 1Y target ₹3,052.5 (2.6% above CMP)
₹3,052.5
2.6% above CMP
₹2,125 – ₹4,200
6 active 1Y targets
10 open
8 BUY · 2 SELL (all horizons)
50%
12 of 24 closed calls hit
Watch GLAND for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (34) · loading…

BUYGLANDGland Pharma1 Year
AI19+·4−+6.4% P&L+11.0% upside left
₹2,974.3
CMP
Entry*
₹2,795.2
Target
₹3,300
RPRajesh Palviya, Axis Securities· via ET Now1w ago
SELLGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI4+·19−-3.2% P&L+24.0% upside left
₹2,974.3
CMP
Target
₹2,260
Entry*
₹2,881.2
CCitigroup· via ET Now (Live)3w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI19+·4−+1.7% P&L+41.2% upside left
₹2,974.3
CMP
Entry*
₹2,924
Target
₹4,200
NWNuvama Wealth· via ET Now (Live)3w ago
SELLGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI4+·19−-4.5% P&L+28.6% upside left
₹2,974.3
CMP
Target
₹2,125
Entry*
₹2,845.5
GSGoldman Sachs· via ET Now (Live)3w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI19+·4−+4.5% P&L+3.6% upside left
₹2,974.3
CMP
Entry*
₹2,845.5
Target
₹3,080
MOMotilal Oswal· via ET Now (Live)3w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI19+·4−+4.5% P&L+12.6% upside left
₹2,974.3
CMP
Entry*
₹2,845.5
Target
₹3,350
JIJefferies India· via Zee Business (Live)3w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI14+·2−+5.43% realised0.0% upside left
SL
₹2,515
Entry*
₹2,845.5
Target
₹3,000
hit 14 Aug 2026, 12:08 pm
VSVikas Sethi, Sethi Finmart· via Zee Business (Live)3w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI11+·2−+13.32% realised0.0% upside left
Entry*
₹2,334
Target
₹2,645
hit 10 Aug 2026, 12:08 pm
ISICICI Securities· via Institutional / Brokerage Research15w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.55% realised0.0% upside left
Entry*
₹1,800.1
Target
₹2,170
hit 18 May 2026, 12:05 pm
ASAxis Securities· via Institutional / Brokerage Research31w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+26.38% realised0.0% upside left
Entry*
₹1,800.1
Target
₹2,275
hit 20 May 2026, 12:05 pm
ISICICI Securities· via Institutional / Brokerage Research31w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.32% realised0.0% upside left
Entry*
₹1,689.7
Target
₹2,050
hit 18 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research31w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.74% realised0.0% upside left
Entry*
₹1,911.8
Target
₹2,270
hit 19 May 2026, 12:05 pm
ISICICI Securities· via Institutional / Brokerage Research43w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.83% realised0.0% upside left
Entry*
₹1,911.8
Target
₹2,310
hit 21 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research43w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.54% realised0.0% upside left
Entry*
₹1,957.5
Target
₹2,340
hit 21 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research56w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.54% realised0.0% upside left
Entry*
₹1,513.95
Target
₹1,840
hit 30 Jun 2025, 12:00 am
MOMotilal Oswal· via Institutional / Brokerage Research83w ago
BUYGLANDGland Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-7.09% realisedNA upside left
₹1,957.5
At expiry
Entry*
₹2,106.95
Target
₹2,440
expired 6 Aug 2025, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research108w ago
BUYGLANDGland Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI19+·5−+4.8% P&L+11.0% upside left
₹2,974.3
CMP
SL
₹2,650
Entry*
₹2,839.4
Target
₹3,300
ABAkshay Bhagwat, JM Financial· via Business Today2w ago
BUYGLANDGland Pharma1–3 Months
AI19+·5−+24.7% P&L+9.3% upside left
₹2,974.3
CMP
Entry*
₹2,384.8
Target
₹3,250
PHPradeep Haldar, PHD Capital· via Business Today6w ago
BUYGLANDGland Pharma1–3 Months
AI19+·5−+27.7% P&L0.0% upside left
₹2,974.3
CMP
SL
₹2,180
Entry
₹2,330
Target
₹2,675
RVRaja Venkatraman· via LiveMint Markets10w ago
BUYGLANDGland Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI19+·5−+32.1% P&L+11.0% upside left
₹2,974.3
CMP
SL
₹2,160
Entry
₹2,251
Target
₹3,300
RBRakesh Bansal· via Zee Business (Live)10w ago
BUYGLANDGland Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·2−+5.40% realised0.0% upside left
SL
₹2,320
Entry
₹2,371.9
Target
₹2,500
hit 30 Jun 2026, 12:06 pm
VRVinay Rajani, HDFC Securities· via NDTV Profit (Live)9w ago
BUYGLANDGland Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI2+·2−-4.65% realisedNA upside left
SL
₹2,400
Entry
₹2,517.1
Target
₹3,100
hit 22 Jul 2026, 12:07 pm
RBRakesh Bansal· via Zee Business (Live)8w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI11+·1−+6.92% realised0.0% upside left
SL
₹2,434
Entry
₹2,544
Target
₹2,720
hit 11 Aug 2026, 9:15 am
SBSumeet Bagadia, Choice Broking· via LiveMint Buy-or-Sell (topic)5w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI4+·1−-2.55% realisedNA upside left
SL
₹2,831
Entry
₹2,905
Target
₹3,070
hit 2 Sept 2026, 9:25 am
ICIDBI Capital· via IDBI Capital Research Calls Telegram1w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI2+·2−-1.40% realisedNA upside left
SL
₹2,500
Entry*
₹2,535.5
Target
₹2,600
hit 30 Jul 2026, 10:40 am
PGPrakash Gaba· via CNBC Awaaz.5w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI1+·1−-2.95% realisedNA upside left
SL
₹2,420
Entry*
₹2,493.5
Target
₹2,600
hit 21 Jul 2026, 11:30 am
AKAshish Kyal, Waves Strategy Advisors· via ET Now (Live)7w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI4+·0−-1.59% realisedNA upside left
SL
₹2,480
Entry*
₹2,520
Target
₹2,650
hit 17 Jul 2026, 9:50 am
SCShrikant Chouhan, Kotak Securities· via CNBC Awaaz.7w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-1.62% realisedNA upside left
SL
₹2,480
Entry*
₹2,520.8
Target
₹2,600
hit 8 Jul 2026, 2:00 pm
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.8w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-2.14% realisedNA upside left
SL
₹2,280
Entry
₹2,329.8
Target
₹2,450
hit 12 Jun 2026, 10:40 am
SSSudeep Shah, SBICAP Securities· via Zee Business (Live)12w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-2.35% realisedNA upside left
₹2,485.5
At expiry
Entry*
₹2,545.2
Target
₹2,900
expired 21 Jul 2026, 3:30 pm
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today8w ago
BUYGLANDGland Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−+2.10% realisedNA upside left
₹2,493.2
At expiry
Entry*
₹2,442
Target
₹2,700
expired 14 Jul 2026, 3:30 pm
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today9w ago
BUYGLANDGland PharmaBTSTExpired
AI3+·0−-1.10% realisedNA upside left
₹2,871.4
At expiry
SL
₹2,850
Entry*
₹2,903.2
Target
₹3,000
expired 27 Aug 2026, 3:20 pm
CTChandan Taparia, Motilal Oswal· via CNBC Awaaz.1w ago
BUYGLANDGland PharmaIntraday* (horizon not stated by the source; assumed from the target's distance)Target hit
AI6+·0−+1.06% realised0.0% upside left
SL
₹2,575
Entry*
₹2,632
Target
₹2,660
hit 10 Aug 2026, 9:15 am
AJAastha Jain, Hem Securities· via Zee Business (Live)4w ago
BUYGLANDGland PharmaIntraday* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-1.34% realisedNA upside left
SL
₹2,215
Entry
₹2,245
Target
₹2,300
hit 23 Jun 2026, 12:03 pm
PGPrakash Gaba· via CNBC Awaaz.10w ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.